Mohammad Reza Mohammadi |  Infection Disease | Research Excellence Award

Posted on by Innovator Awards

Mr. Mohammad Reza Mohammadi |  Infection Disease | Research Excellence Award

Tarbiat Modares University | Iran 

He is a highly motivated researcher with advanced training in medical microbiology and a strong foundation in cellular and molecular biology. His academic background reflects a deep engagement with infectious disease research, particularly in the molecular detection and epidemiological investigation of clinically significant and neglected pathogens. His postgraduate research focused on the molecular identification of fastidious and unculturable bacterial agents associated with culture-negative endocarditis using advanced real-time polymerase chain reaction techniques, contributing valuable insights into diagnostic microbiology and clinical pathogen surveillance. His research expertise spans zoonotic diseases, molecular epidemiology, and neglected tropical diseases, with a strong emphasis on pathogen detection, diagnostic innovation, and molecular characterization. He demonstrates interdisciplinary competence across microbiology, molecular biology, and bioinformatics-supported meta-analysis approaches, enabling integrative research design and data interpretation. His work reflects a commitment to improving diagnostic accuracy, strengthening infectious disease surveillance systems, and advancing translational microbiological research. With a strong analytical mindset and research-driven approach, he shows high potential for impactful contributions in clinical microbiology, global health research, and molecular infectious disease science.

Citation Metrics (Google Scholar)

800
600
400
200
0

Citations
460

Documents
11

h-index
12

Citations

Documents

h-index


View Google Scholar Profile

Featured Publications


Global prevalence and genetic diversity of Cryptosporidium spp. in pigeons: a systematic review and meta-analysis

F Mahdavi, M Mamizadeh, MR Mohammadi, A Pouryousef, G Sgroi, ...
Comparative Immunology, Microbiology and Infectious Diseases, Article 102437, 2025


Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

SB Sirota, RG Bender, RMV Dominguez, A Movo, LR Swetschinski, ...
The Lancet Infectious Diseases, 2025


Prevalence of Free-Living Amoebae in Various Water Sources in Iran: A Systematic Review and Meta-Analysis

L Shamsi, M Mamizadeh, MR Mohammadi, A Pouryousef, M Kheiry, ...
Acta Parasitologica 70(6): 220, 2025


Probiophage: A Novel Candidate for the Treatment of Irritable Bowel Disease (IBD): A Systematic Review

A Rahi, R Azizian, MR Mohammadi, N Namadiyam, A Azimi, M Hamidi
The Open Microbiology Journal 19(1), 2025

Aayushi Rastogi | Non-communicable diseases | Young Scientist Award

Posted on by Innovator Awards

Ms. Aayushi Rastogi | Non-communicable diseases | Young Scientist Award

Institute of Liver and Biliary Sciences | India

Aayushi Rastogi is a public-health researcher specializing in liver-disease epidemiology, with a strong focus on diabetes-associated liver conditions, screening models, and health-systems strengthening. Her work integrates epidemiologic methods with primary-care program implementation to advance early detection and management of liver fibrosis. She has contributed to more than 30 peer-reviewed publications and has played key roles in protocol development, study coordination, quantitative analysis, and manuscript preparation. Her doctoral research examined the prevalence and predictors of liver fibrosis among individuals with diabetes, generating evidence highly relevant for community-based screening initiatives. A major contribution of her work is the development of a practical, low-resource fibrosis-risk score tailored for primary-care settings. This tool uses minimal clinical and laboratory parameters to stratify risk and guide referral pathways, thereby enhancing accessibility of liver-disease assessment at the frontline level. She has also contributed to health-systems research, capacity-building programs, and CSR-supported public-health initiatives, including screening, tele-mentoring, and community engagement projects. With expertise in epidemiologic design, STATA-based data analysis, and implementation research, her work advances evidence-based strategies for early detection, risk stratification, and strengthening of liver-health services, ultimately supporting improved care models for populations at risk of chronic liver disease.

Citation Metrics (Google Scholar)

400
300
200
100
0

Citations
188

Documents
8

h-index
8

Citations

Documents

h-index


View Google Scholar Profile

Featured Publications

Murtaza Jafari | Medical and Clinical Biochemistry and Pharmaceutics | Best Researcher Award

Posted on by Innovator Awards

Dr. Murtaza Jafari | Medical and Clinical Biochemistry and Pharmaceutics | Best Researcher Award

Cheragh University of Medical Sciences | Afghanistan

Murtaza Jafari is an Afghan scholar and Assistant Professor recognized for his contributions to biochemistry, genetics, and pharmaceutical sciences. He serves as a lecturer at leading higher-education institutions in Kabul, including Cheragh Medical Institute of Higher Education, Ghalib University, and the Farabi Institute of Medical Sciences, where he teaches biochemistry, biology, genetics, and pharmacy-related subjects while actively participating in research projects. He holds a Doctor of Pharmacy degree from Kabul University and a Master of Science from Persian Gulf University, specializing in biochemical research and nanotechnology-based applications. His academic work includes the synthesis and application of cobalt ferrite magnetic nanoparticles coated with PEG and PEI, focusing on their use in purifying free and genomic DNA, as well as advancing magnetic nanoparticle-assisted DNA extraction methods. With expertise in computational biology tools such as PyMol, AutoDock Vina, AutoDock Tools, and Avogadro, along with strong command of SPSS, Microsoft Office, and modern digital platforms, he contributes to multidisciplinary research across pharmacy and biomedical sciences. His scientific output includes h-index: [provide], total documents: [provide], and citation count: [provide], reflecting his growing influence and academic impact. Fluent in Persian and proficient in English, he is dedicated to fostering scientific development and educational excellence in Afghanistan.

Profile: Google Scholar 

Featured Publications 

Jafari, M. (2022). Microbiological quality (yeast and mold) of dried fruits in Kabul, Afghanistan: A laboratory study. Global Scientific Review, 1, 19–28.

Jafari, M., Shahryar, S., Mohebbi, S., Ahmadi, A., Nazari, R., Haidari, A. R., … (2025). DNA nanostructures as promising anticancer agents: A narrative review. Cancer Treatment and Research Communications, 101029.

Amiri, S. H., Danish, S. M., Azimi, A. W., & Jafari, M. (2024). Gastric cancer incidence among patients referred to Jamhuriat Hospital, Kabul, Afghanistan: A cross-sectional study, 2023. American Journal of Pedagogical and Educational Research, 23.

Tawakuli, Y., Nazari, R., Rasoli, M. R., Jafari, M., & Sultani, F. (2022). Evaluation of narcotics prescribed in surgery: A descriptive study in Kabul, Afghanistan, 2022. Texas Journal of Medical Science, 10, 76–80.

Tawakuli, Y., Jafari, M., Taib, A., & Amiri, S. H. (2022). Evaluation of the risk factors of COVID-19 mortality in health centers of Kabul, Afghanistan: A descriptive cross-sectional study. American Journal of Technology and Applied Sciences, 3, 35–40.

Prof. Zhiguo Wang – Polypharmacology – Outstanding Scientist Award

Posted on by Innovator Awards

Prof. Zhiguo Wang - Polypharmacology - Outstanding Scientist Award

Guangdong Provincial Key Laboratory for Mechanistic and Translational Research on Bidirectional Complications among Chronic Conditions, Jinan University, China - China 

Author Profile

SCOPUS 

ORCID

GOOGLE SCHOLAR

Early academic pursuits 🎓

Zhiguo Wang embarked on his academic journey with a strong foundation in pharmacology, pursuing his studies at Harbin Medical University in Heilongjiang, China. His early work laid the groundwork for a distinguished career focused on understanding chronic diseases and their complex interrelations. His rigorous training and commitment to research established him as a formidable scholar in the field of cardiovascular and chronic disease research.

Professional endeavors 🏢

Throughout his career, Zhiguo has held numerous prestigious positions, demonstrating his leadership in the medical and research communities. He is currently the Director and Professor at the Guangdong Provincial Key Laboratory for Mechanistic and Translational Research on Chronic Disease Complex Complications at Jinan University in Guangzhou, China. His role as a chief scientist and professor across various departments at the First Affiliated Hospital of Jinan University reflects his multifaceted expertise. Additionally, he has contributed significantly as a Distinguished Professor at Harbin Medical University and held a visiting professorship at the Montreal Heart Institute in Canada.

Contributions and research focus 🔬

Zhiguo's research focuses on the mechanistic and translational aspects of chronic diseases, particularly the bidirectional complications arising from these conditions. He has pioneered studies that explore the pathophysiology of cardiovascular diseases and their links to metabolic disorders. His work employs innovative Polypharmacology methodologies to investigate the underlying mechanisms of disease progression and to develop effective therapeutic strategies, aiming to improve patient outcomes in chronic disease management.

Accolades and recognition 🏅

Zhiguo Wang has received numerous accolades for his contributions to medical research, including being a Fellow of the American Heart Association (FAHA) and a Polypharmacology Fellow of the European Society of Cardiology (FESC). His recognition as a Marion L. Munro Research Scholar by the Canadian Diabetes Association further underscores his impactful research in chronic disease mechanisms. His extensive publication record in high-impact journals reflects his influence and standing in the academic community.

Impact and influence 🌍

Zhiguo's research has made a significant impact on the understanding of chronic diseases and their complications, influencing both clinical practice and public health strategies. His work is instrumental in bridging the gap between basic science and clinical applications, ultimately contributing to improved therapeutic approaches Polypharmacology for patients suffering from chronic conditions. He is a sought-after speaker and mentor, inspiring the next generation of researchers in his field.

Legacy and future contributions 🔮

As a leader in chronic disease research, Zhiguo Wang’s legacy is built on his commitment to advancing scientific knowledge and improving patient care. His ongoing research aims to unravel the complexities of chronic disease interactions and to foster innovative therapeutic strategies. With a focus on translational research, Zhiguo's future contributions are poised to drive significant advancements in understanding and treating chronic conditions, leaving a lasting impact on the field and enhancing healthcare outcomes globally.

Notable Publications 

Topical GDF11 accelerates skin wound healing in both type 1 and 2 diabetic mouse models  2020(9)

Metformin Shortens Prolonged QT Interval in Diabetic Mice by Inhibiting L-Type Calcium Current 2020(8)

Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143/EGR1 axis 2020(38)

Increase of late sodium current contributes to enhanced susceptibility to atrial fibrillation in diabetic mice 2019(22)

Systematic analysis of intestinal microRNAs expression in HCC: Identification of suitable reference genes in fecal samples 2019(4)